Could histologic healing be a new treatment target in patients with ulcerative colitis?

참고문헌 (11)

1. Song EM, "Natural history of inflammatory bowel disease : a comparison between the East and the West", Intest Res, 20, pp.418~430 (2022)
2. Turner D, "STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treatto-target strategies in IBD", Gastroenterology, 160, pp.1570~1583 (2021)
3. Seong G, "Histologic activity and steroid use history are risk factors of clinical relapse in ulcerative colitis with Mayo endoscopic subscore of 0 or 1", Inflamm Bowel Dis, 29, pp.238~244 (2023)
4. Jangi S, "Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing", Aliment Pharmacol Ther, 52, pp.1008~1016 (2020)
5. Shin SY, "Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity", Korean J Intern Med (2023)[DOI]
6. Bressenot A, "Comparing histological activity indexes in UC", Gut, 64, pp.1412~1418 (2015)
7. Korelitz BI, "Mucosal healing as an index of colitis activity : back to histological healing for future indices", Inflamm Bowel Dis, 16, pp.1628~1630 (2010)
8. Peyrin-Biroulet L, "Histologic remission : the ultimate therapeutic goal in ulcerative colitis?", Clin Gastroenterol Hepatol, 12, pp.929~934 (2014)
9. Ullman TA, "Intestinal inflammation and cancer", Gastroenterology, 140, pp.1807~1816 (2011)
10. Ahmad HA, "Artificial intelligence in inflammatory bowel disease : implications for clinical practice and future directions", Intest Res, 21, pp.283~294 (2023)
11. Takenaka K, "Artificial intelligence for endoscopy in inflammatory bowel disease", Intest Res, 20, pp.165~170 (2022)

관련 논문AI추천